Publication: 3395

Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance)
      QxMD      Google Scholar   
Citation:
Oncologist vol 27 (5) 338-e368
Year:
2022
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
collection
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
11
Parents:
341  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, UG1CA232760  
Corr. Author:
 
Authors:
                           
Networks:
LAPS-MN026, OH016, PR028, SANFORD   
Study
NCCTG-N1031
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
pixantrone, breast cancer, anthracycline, randomized phase II, cardiotoxicity